CHF Solutions raises nearly $2 million

BROOKLYN PARK, Minnesota– CHF Solutions Inc. raised $1.8 million from investors, according to documents filed with the Securities and Exchange Commission.

The company is seeking a total of $2.3 million from the sale of equity.

Founded in 1999, CHF’s core technology is the Aquadex FlexFlow System, a device that removes excess fluids, primarily water, from the blood of patients suffering from congestive heart failure, renal failure, metabolic diseases and post-surgery complications.

CHF president and CEO David Springer did not immediate return a call for comment.